Live Oak Health Sciences Fund (LOGSX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital growth. The fund invests primarily in common stocks of companies engaged in the research- development- production- or distribution of products or services related to health care- medicine- or the life sciences. It will invest at least 80% of its net assets- under normal circumstances- in equity securities of health science companies. The fund invests primarily in common stocks of U.S. companies- but may- to a lesser extent- invest in common stocks of foreign companies and American Depositary Receipts ("ADRs") that meet the investment criteria of the fund.


1 month-0.72% 3 years+4.42%
3 months-0.61% 5 years+12.97%
1 year+4.20% Since inception+7.71%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+12.97%+17.28%
Expense ratio1.01%1.30%
Risk 5 year sharpe ratio1.151.02
Net assets$63.4M$3.1B
Average market cap$43.7B$10.4B
Average P/E19.422.9
Portfolio turnover14%14%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyOak Associates
Fund manager & tenureMark Oelschlager / 16 Years
Minimal initial investment$2,000.00
Minimum IRA investment--


U.S. stock80.40%
International stock14.41%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 95.95%
Consumer service 4.05%
Business service 0.00%
Consumer goods 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen7.00%
ANTM WellPoint5.98%
ESRX Express Scripts Holding Co5.84%
BIIB Biogen5.31%
WAT Waters Corp4.95%
MCK McKesson Corp4.66%
DVA Davita Inc4.37%
AET Aetna3.96%
UNH UnitedHealth3.89%
CAH Cardinal Health Inc3.72%